77822 PSD95-nNOS interaction alters the basolateral amygdala transcriptome following fear conditioning: implications for molecular mechanisms underlying PTSD

dc.contributor.authorPatel, Jheel
dc.contributor.authorHaulcomb, Melissa
dc.contributor.authorLi, Liangping
dc.contributor.authorJiang, Guanglong
dc.contributor.authorDustrude, Erik
dc.contributor.authorLiu, Yunlong
dc.contributor.authorLai, Yvonne
dc.contributor.authorMolosh, Andrei
dc.contributor.authorShekhar, Anantha
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2025-01-28T20:01:43Z
dc.date.available2025-01-28T20:01:43Z
dc.date.issued2021
dc.description.abstractABSTRACT IMPACT: This research takes a transcriptomic approach to parse genes and molecular pathways that underlie the fear memory circuitry and, in doing so, identifies therapeutic targets that can further be developed into treatments for fear disorders, such as post-traumatic stress disorder. OBJECTIVES/GOALS: Normal fear learning produces avoidance behavior that promotes survival, but excessive and persistent fear after trauma can lead to development of phobias and post-traumatic stress disorder (PTSD). Our goal is to understand the mechanism and identify novel genetic targets underlying fear responses. METHODS/STUDY POPULATION: Involvement of the basolateral amygdala (BLA) in fear acquisition is well established and requires activation of N-methyl-D-aspartic acid receptors (NMDARs). At a cellular level, NMDAR activation leads to production of nitric oxide (NO) by a process mediated by interaction between postsynaptic density protein 95 (PSD95) and neuronal nitric oxide synthase (nNOS). To elucidate mechanisms underlying the role of the PSD95-nNOS-NO pathway in conditioned fear, here we use rodent behavioral paradigms, pharmacological treatment with a small molecule PSD95-nNOS inhibitor, RNA-sequencing, and an AAV-mediated knockdown of the nNOS gene in the BLA. RESULTS/ANTICIPATED RESULTS: We show that treatment with ZL006 attenuates rodent cued-fear consolidation. Additionally, with RNA-sequencing, expression of 516 genes was altered in the BLA following fear expression; of these genes, 83 were restored with systemic ZL006 treatment. Network data and gene ontology enrichment analyses further revealed that cGMP effects, insulin-like growth factor binding, and cognition-related pathways were significantly altered. Finally, we show that a BLA-specific knockdown of nNOS attenuates cued fear consolidation, without adverse effects on other memory and motor behaviors. DISCUSSION/SIGNIFICANCE OF FINDINGS: Via a model of NMDAR-mediated fear consolidation, our results reveal novel pathways and genetic targets that underlie plasticity of fear memory circuitry. Importantly, these results will inform future therapeutic strategies for targeting fear related disorders like PTSD.
dc.eprint.versionFinal published version
dc.identifier.citationPatel J, Haulcomb M, Li L, et al. 77822 PSD95-nNOS interaction alters the basolateral amygdala transcriptome following fear conditioning: implications for molecular mechanisms underlying PTSD. Journal of Clinical and Translational Science. 2021;5(s1):23-23. doi:10.1017/cts.2021.463
dc.identifier.urihttps://hdl.handle.net/1805/45556
dc.language.isoen_US
dc.publisherCambridge University Press
dc.relation.isversionof10.1017/cts.2021.463
dc.relation.journalJournal of Clinical and Translational Science
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.sourcePublisher
dc.subjectPost-traumatic stress disorder
dc.subjectGenes
dc.subjectMolecular pathways
dc.subjectFear memory circuitry
dc.title77822 PSD95-nNOS interaction alters the basolateral amygdala transcriptome following fear conditioning: implications for molecular mechanisms underlying PTSD
dc.typeAbstract
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Patel2021Interaction-CCBY.pdf
Size:
54.57 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: